γToc inhibited the proliferation of human breast cancer cells in vitro [52, 61], delayed the formation of breast cancer tumours in rodent models [52], and induced apoptosis in breast cancer cells via upregulation of DR5 expression [60]. This evidence concerns the gene TNFRSF10B and breast carcinoma.